Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
Medical Grand Rounds

Role of uric acid in hypertension, renal disease, and metabolic syndrome

Marcelo Heinig, MD and Richard J. Johnson, MD
Cleveland Clinic Journal of Medicine December 2006, 73 (12) 1059-1064;
Marcelo Heinig
Division of Nephrology, Hypertension, and Transplantation, University of Florida, Gainesville
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard J. Johnson
J. Robert Cade Professor of Medicine, Division of Nephrology, Hypertension, and Transplantation, University of Florida, Gainesville
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: marcelo.heinig@medicine.ufl.edu
  • Article
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Hyperuricemia has long been known to be associated with cardiovascular disease, and it is particularly common in people with hypertension, metabolic syndrome, or kidney disease. Most authorities have viewed elevated uric acid as a secondary phenomenon that is either innocuous or perhaps even beneficial, since uric acid can be an antioxidant. However, recent experiments have challenged this viewpoint. In this paper we argue that uric acid is a true risk factor for cardiovascular disease. Furthermore, we suggest that the recent increased intake in the American diet of fructose, which is a known cause of hyperuricemia, may be contributing to the current epidemic of obesity and diabetes.

Footnotes

  • ↵* The author has indicated that he serves as a consultant to Scios and Tap Pharmaceuticals, is a member of the speakers bureau of Merck Pharmaceuticals, and is a board member of Nephronomics. His work is supported by NIH grants DK-52121, HL-68607, and HL-79352.

  • Copyright © 2006 The Cleveland Clinic Foundation. All Rights Reserved.
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 73 (12)
Cleveland Clinic Journal of Medicine
Vol. 73, Issue 12
1 Dec 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of uric acid in hypertension, renal disease, and metabolic syndrome
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Role of uric acid in hypertension, renal disease, and metabolic syndrome
Marcelo Heinig, Richard J. Johnson
Cleveland Clinic Journal of Medicine Dec 2006, 73 (12) 1059-1064;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Role of uric acid in hypertension, renal disease, and metabolic syndrome
Marcelo Heinig, Richard J. Johnson
Cleveland Clinic Journal of Medicine Dec 2006, 73 (12) 1059-1064;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Fingolimod Phosphate (FTY720-P) Activates Protein Phosphatase 2A in Human Monocytes and Inhibits Monosodium Urate Crystal-Induced Interleukin-1{beta} Production
  • Monosodium Urate Contributes to Retinal Inflammation and Progression of Diabetic Retinopathy
  • Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway
  • Association between Serum Free Thyroxine (FT4) and Uric Acid Levels in Populations without Overt Thyroid Dysfunction
  • Serum Urate and Incidence of Kidney Disease Among Veterans with Gout
  • Remote Communication through Solute Carriers and ATP Binding Cassette Drug Transporter Pathways: An Update on the Remote Sensing and Signaling Hypothesis
  • Posing the Question Again: Does Chronic Uric Acid Nephropathy Exist?
  • Trp64Arg Polymorphism of the ADRB3 Gene Predicts Hyperuricemia Risk in a Population from Southern Spain
  • Daily Consumption of an Aqueous Green Tea Extract Supplement Does Not Impair Liver Function or Alter Cardiovascular Disease Risk Biomarkers in Healthy Men
  • Elevated Uric Acid Increases the Risk for Kidney Disease
  • Association of Incident Gout and Mortality in Dialysis Patients
  • Cardiovascular Literature--Beyond Nephrology
  • Plasma Uric Acid and the Risk of Type 2 Diabetes in a Chinese Community
  • The Fructose Nation
  • Metabolic Syndrome: An Emerging Threat to Renal Function
  • Serum Concentrations of Uric Acid and the Metabolic Syndrome Among US Children and Adolescents
  • Google Scholar

More in this TOC Section

  • Steroids in the acutely ill: Evolving recommendations and practice
  • Evaluation and management of orthostatic hypotension: Limited data, limitless opportunity
  • Options for preserving fertility in women undergoing gonadotoxic treatment
Show more Medical Grand Rounds

Similar Articles

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire